Silvia Daniela da Costa Teixeira

Fairjourney Biologics SA is a biologics contract research organization that provides integrated services across antibody discovery, engineering, and production to biopharma. The Portuguese company operates a flexible, customer-oriented ‘ one-stop shop ’ approach to biologics development focused on quality, reliability, and partnership. Fairjourney Biologics has successfully completed more than 500 projects for over 100 customers across big pharma and leading biotech companies to date. The company's innovative mammalian display platform enables full-length antibodies to be expressed in the context of a mammalian cell, allowing selection based on function, stability, expression, and developability. The company has grown to over 130 highly technically skilled employees today and has subsidiaries in the United Kingdom. Fairjourney Biologics was founded in 2012 by António Bernadino Guimaraes Parada and Maria Gonzalez Pajuelo and is headquartered in Porto, PT. António Bernadino Guimaraes Parada has been the CEO since 2012.